TOWA Pharmaceutical Co's Total Assets for the quarter that ended in Dec. 2023 was 円414,685 Mil.
During the past 12 months, TOWA Pharmaceutical Co's average Total Assets Growth Rate was 15.50% per year.
During the past 3 years, the average Total Assets Growth Rate was 21.60% per year.
During the past 5 years, the average Total Assets Growth Rate was 20.30% per year.
During the past 10 years, the average Total Assets Growth Rate was 15.00% per year.
During the past 13 years, TOWA Pharmaceutical Co's highest 3-Year average Total Assets Growth Rate was 24.00%. The lowest was 4.80%. And the median was 14.70%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.
TOWA Pharmaceutical Co's Total Assets for the fiscal year that ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TOWA Pharmaceutical Co (TSE:4553) Total Assets Explanation
Note:
The Net Income data used here is four times the quarterly (Dec. 2023) data.
In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.
Total Assets is linked to total revenue through Asset Turnover.
TOWA Pharmaceutical Co's Asset Turnover for the quarter that ended in Dec. 2023 is
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.
TOWA Pharmaceutical Co Total Assets Related Terms
Thank you for viewing the detailed overview of TOWA Pharmaceutical Co's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.
TOWA Pharmaceutical Co (TSE:4553) Business Description
TOWA Pharmaceutical Co Ltd is a Japan based pharmaceutical company engaged in research and development, production, and marketing of generic drugs. It also provides drug consulting services for patients and their families and relatives. It organizes academic seminars for medical professionals and posts articles in journals. It participates in training for pharmacists. The company has three main plants in operation namely Osaka plant, Okayama plant, and Yamagata plant. Towa has offers more than 500 drugs to meet the diverse therapeutic requirements including lifestyle related diseases such as hypertension and diabetes, digestive system diseases, nervous system diseases and allergic diseases, vitamins and antibiotics.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
TSE:4553 has been successfully added to your 